Join the Endari group to help and get support from people like you.
Endari News
Emmaus Life Sciences Receives FDA Approval for Endari Label Enhancements
Torrance CA, June 26, 2025 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that it has received Food and Drug Administration (FDA) approval for...
FDA Approves Endari (L-glutamine oral powder) for Sickle Cell Disease
July 7, 2017 – The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications...